Moderna Inc (MRNA) — Capital Reinvestment Ratio
Moderna Inc (MRNA) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow ($951.00 Million) in capital expenditures ($39.00 Million). Check MRNA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Moderna Inc Capital Reinvestment Ratio (2016–2022)
This chart tracks Moderna Inc's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see Moderna Inc (MRNA) cash flow conversion.
Annual Capital Reinvestment Ratio for Moderna Inc (2016–2022)
Year-by-year Capital Reinvestment Ratio for Moderna Inc from 2016 to 2022. See Moderna Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.08x | $4.98 Billion | $400.00 Million | ▲ +285.1% |
| 2021 | 0.02x | $13.62 Billion | $284.00 Million | ▼ -37.3% |
| 2020 | 0.03x | $2.03 Billion | $67.45 Million | ▼ -93.3% |
| 2016 | 0.50x | $66.73 Million | $33.14 Million | — |